Aug 18, 2021· Comment from American Pharmacists Association· FDA-2018-D-0338-0014
Please see the attached comments of the American Pharmacists Association (APhA).
FDANonrulemakingFDA-2018-D-0338
Definitions of Suspect Product and Illegitimate Product for Verification Obligations Under the Drug Supply Chain Security Act
RIN
—
Last modified
Mar 16, 2023
Comment window
closed 3039d ago
American Pharmacists Association (APhA) filings
2
Activity
American Pharmacists Association (APhA) filed 2 comments on this docket between Apr 3, 2018 and Aug 18, 2021. 6 other organizations filed here. The comment window closed 3039d ago.
What American Pharmacists Association (APhA) filed (2)
Apr 3, 2018· Comment from American Pharmacists Association (APhA)· FDA-2018-D-0338-0005
Please see attached for comments from the American Pharmacists Association.
Abstract
No abstract recorded.
View on regulations.gov →Co-filers (6)
See everyone who commented →- American Pharmacists Association (APhA)THIS ORG2 filings · confidence 97%
- Healthcare Distribution Alliancetrade assoc.2 filings · confidence 85%
- Pharmaceutical Distribution Security Alliancetrade assoc.2 filings · confidence 85%
- Healthcare Supply Chain Associationtrade assoc.1 filing · confidence 85%
- McKesson Corporationunverified attribution1 filing · confidence 70%
- National Association of Boards of Pharmacytrade assoc.1 filing · confidence 85%
- National Association of Chain Drug Storestrade assoc.1 filing · confidence 97%